Bullish
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Genmab announced positive results from two Phase 1b/2 and Phase 2 trials (EPCORE DLBCL-3 and EPCORE NHL-2) evaluating epcoritamab in elderly patients ...